| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | J05AP08 |
| UNII | WJ6CA3ZU8B |
| InChI Key | TTZHDVOVKQGIBA-IQWMDFIBSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H29FN3O9P |
| Molecular Weight | 529.46 |
| AlogP | 1.66 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 158.18 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 36.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor | INHIBITOR | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | - | - | - | 61 | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | - | - | - | 61 | |
|
Enzyme
Transferase
|
34-589 | - | - | - | - |
| Resources | Reference |
|---|---|
| ChEBI | 85083 |
| ChEMBL | CHEMBL1259059 |
| DrugBank | DB08934 |
| DrugCentral | 4811 |
| FDA SRS | WJ6CA3ZU8B |
| Guide to Pharmacology | 7368 |
| PharmGKB | PA166122593 |
| PubChem | 45375808 |
| SureChEMBL | SCHEMBL2010114 |
| ZINC | ZINC000100074252 |